Cargando…

Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations

BACKGROUND: Anemia is a frequent finding in cancer patients. Pre-treatment anemia is known to be associated with poor survival after surgery or stereotactic body radiation therapy of non-small cell lung cancer (NSCLC). However, little study was conducted in NSCLC with activating epidermal growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Hye Seon, Shin, Ah Young, Yeo, Chang Dong, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Lee, Sang Haak, Kim, Sung Kyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330305/ https://www.ncbi.nlm.nih.gov/pubmed/32642093 http://dx.doi.org/10.21037/jtd-19-3932

Ejemplares similares

Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
por: Yeo, Chang Dong, et al.
Publicado: (2019)

Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide‐platinum‐atezolizumab treatment
por: Lim, Jeong Uk, et al.
Publicado: (2022)

The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker
por: Kim, Seohyun, et al.
Publicado: (2023)

Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
por: Nam, Jung Hyun, et al.
Publicado: (2023)

Smoking is associated with pneumonia development in lung cancer patients
por: Heo, Jung Won, et al.
Publicado: (2020)

Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients
por: Heo, Jung Won, et al.
Publicado: (2020)

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
por: Ban, Woo Ho, et al.
Publicado: (2020)

The Value of Residual Volume/Total Lung Capacity as an Indicator for Predicting Postoperative Lung Function in Non-Small Lung Cancer
por: Kwon, Oh-Beom, et al.
Publicado: (2021)

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Prediction of Postoperative Lung Function in Lung Cancer Patients Using Machine Learning Models
por: Kwon, Oh Beom, et al.
Publicado: (2023)

Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis
por: Lim, Jeong Uk, et al.
Publicado: (2022)

Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study
por: Lim, Jeong Uk, et al.
Publicado: (2020)

Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
por: Kim, Hyeongbin, et al.
Publicado: (2019)

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea
por: Kang, Hye Seon, et al.
Publicado: (2022)

Clinical significance of microbial colonization identified by initial bronchoscopy in patients with lung cancer requiring chemotherapy
por: Kang, Ji Young, et al.
Publicado: (2021)

Clinical characteristics and survival of patients concurrently diagnosed with lung cancer and active pulmonary tuberculosis
por: Lee, Hwa Young, et al.
Publicado: (2022)

Prognostic Significance of Nuclear Survivin Expression in Resected Adenoid Cystic Carcinoma of the Head and Neck
por: Ko, Yoon Ho, et al.
Publicado: (2010)

Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer
por: Kang, Hye Seon, et al.
Publicado: (2020)

Discordance of Epidermal Growth Factor Receptor Mutation between Brain Metastasis and Primary Non-Small Cell Lung Cancer
por: Kim, Kyung-Min, et al.
Publicado: (2019)

The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer
por: Kim, Ji Yea, et al.
Publicado: (2022)

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Clinical Significance of Signet-Ring-Cell Colorectal Cancer as a Prognostic Factor
por: Yun, Sang-Oh, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease
por: Ban, Woo Ho, et al.
Publicado: (2018)

Factors Related to the Diagnostic Yield of Flexible Bronchoscopy without Guidance in Bronchoscopically Invisible Peripheral Lung Lesions
por: Kang, Hye Seon, et al.
Publicado: (2017)

Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Anatomical location of AICA loop in CPA as a prognostic factor for ISSNHL
por: Kim, Sang Hyub, et al.
Publicado: (2019)

The use of epidermal growth factor in dermatological practice
por: Shin, Sun Hye, et al.
Publicado: (2022)

Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting
por: Nam, Yunha, et al.
Publicado: (2021)

Clinical features and prognostic factors of Churg-Strauss syndrome
por: Kim, Mi-Yeong, et al.
Publicado: (2014)

Laboratory prognostic factors for the long-term survival of multiple system atrophy
por: Shin, Jung Hwan, et al.
Publicado: (2022)

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
por: Lee, Jang Ho, et al.
Publicado: (2023)

Clinical Significance of National Patients Sample Analysis: Factors Affecting Mortality and Length of Stay of Organophosphate and Carbamate Poisoned Patients
por: Kim, Kyoung-Ho, et al.
Publicado: (2013)

Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer
por: Paik, Soo-Hyun, et al.
Publicado: (2019)

Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
por: Kim, Seung Tae, et al.
Publicado: (2013)

Factors Prognostic of Season-Associated Sudden Sensorineural Hearing Loss: A Retrospective Observational Study
por: Ryu, In Yong, et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations
por: Lim, Jeong Uk, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d0out8por43uf6dngvk8unh96d